View speaker details

Helen Chen is the Managing Partner of L.E.K. Consulting based in Shanghai. She sat on L.E.K.’s Global Leadership Team, the firm’s governing board, from 2012 to 2016. Helen has over 30 years of consulting and industry experience in the U.S. and Asia, and has resided in China since 2000.

Helen is the head of L.E.K.’s China and Asia life sciences practice, with extensive case work and industry experience covering the full biopharmaceutical and medtech value chain, ranging from early research services to post-market product positioning and sales force effectiveness. In China, she has developed commercial strategies for international medtechs, investment thesis for financial investors, business plans for domestic startups and policy analyses for industry associations.

Helen produced the 2016 Shanghai government commissioned Chinese outbound investment guide From China to the World: An International Investment and Market Access Guide for Chinese Biopharmaceutical Companies. She is a frequent speaker and author on the opportunities and issues in the China healthcare and life sciences, and has been quoted by publications including BioCentury, BioWorld, In Vivo, Wall Street Journal, Financial Times and Forbes Asia.

Prior to joining L.E.K., Helen held senior management roles at a number of technology companies in the U.S. and China. She was an associate director of finance at Genentech and a sales planner at Abbott Laboratories. She is on the organising committee for the Medtronic Sequoia Fund, and was on the Board of Pharmaceutical Management Sciences Association from 1995 to 1997.

Helen received her A.B. cum laude in applied mathematics from Harvard University.

View speaker details

Justin Wang is a Partner in L.E.K.’s Shanghai office, and a leader in L.E.K. China’s Life Science practice.

Justin has 16 years of experience in strategic consulting, advising Chinese and international clients in pharmaceutical, medical technology, and healthcare service sectors.

Justin has extensive experience in strategy planning, sales and marketing, pricing and market access, as well as supporting M&A and licensing transactions. Justin also actively advises domestic Chinese clients in exploring overseas expansion and investment opportunities.

Justin frequently speaks at industry forums on market trends and insights. He has also published many articles in trade journals. In 2015 he co-authored a guidebook for biopharma and healthcare companies targeting the international markets: From China to the World: An International Investment and Market Access Guide for Chinese Biopharmaceutical Companies.

Justin has been with L.E.K. in China since 2003. He has also worked in L.E.K.’s London office. Justin graduated from Fudan University in China, majoring in International Finance. He is fluent in both Chinese Mandarin and English.